PA

Perceptive Advisors Portfolio holdings

AUM $2.67B
1-Year Return 73.17%
This Quarter Return
+18.66%
1 Year Return
+73.17%
3 Year Return
+837.18%
5 Year Return
+928.4%
10 Year Return
+11,818.46%
AUM
$1.23B
AUM Growth
+$120M
Cap. Flow
+$14.7M
Cap. Flow %
1.2%
Top 10 Hldgs %
49.61%
Holding
221
New
48
Increased
36
Reduced
31
Closed
51

Top Buys

1
NXTM
NxStage Medical Inc.
NXTM
$30M
2
MDVN
MEDIVATION, INC.
MDVN
$25.3M
3
STJ
St Jude Medical
STJ
$18.2M
4
GBT
Global Blood Therapeutics, Inc.
GBT
$15.1M
5
LJPC
La Jolla Pharmaceutical Company
LJPC
$10.1M

Top Sells

1
AGN
Allergan plc
AGN
$41.5M
2
HUM icon
Humana
HUM
$20.1M
3
FPRX
Five Prime Therapeutics, Inc.
FPRX
$11.8M
4
BAX icon
Baxter International
BAX
$9.04M
5
CPXX
CELATOR PHARMACEUTICALS INC. COMMON STOCK
CPXX
$7.9M

Sector Composition

1 Healthcare 89.18%
2 Consumer Discretionary 0.09%
3 Consumer Staples 0.05%
4 Financials 0.04%
5 Industrials 0.04%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
ALDX icon
26
Aldeyra Therapeutics
ALDX
$332M
$11M 0.77%
1,940,458
+700,000
+56% +$3.98M
WVE icon
27
Wave Life Sciences
WVE
$1.3B
$10.8M 0.75%
522,595
+346,595
+197% +$7.17M
SNDA icon
28
Sonida Senior Living
SNDA
$486M
$10.4M 0.72%
39,076
+2,767
+8% +$733K
ALDR
29
DELISTED
Alder Biopharmaceuticals, Inc.
ALDR
$9.99M 0.69%
400,000
+25,000
+7% +$624K
DXCM icon
30
DexCom
DXCM
$31.7B
$9.93M 0.69%
500,696
+394,800
+373% +$7.83M
QURE icon
31
uniQure
QURE
$973M
$9.89M 0.69%
1,342,093
-100,000
-7% -$737K
TEVA icon
32
Teva Pharmaceuticals
TEVA
$21.2B
$9.85M 0.68%
196,000
-65,000
-25% -$3.26M
CRBP icon
33
Corbus Pharmaceuticals
CRBP
$123M
$9.57M 0.66%
106,667
+65,000
+156% +$5.83M
BPMC
34
DELISTED
Blueprint Medicines
BPMC
$9.4M 0.65%
464,404
+60,000
+15% +$1.21M
AGTC
35
DELISTED
Applied Genetic Technologies Corporation
AGTC
$9.31M 0.65%
658,851
+8,260
+1% +$117K
RGNX icon
36
Regenxbio
RGNX
$476M
$8.79M 0.61%
1,099,213
+273,817
+33% +$2.19M
NERV icon
37
Minerva Neurosciences
NERV
$16.2M
$8.28M 0.57%
101,317
– –
CDTX icon
38
Cidara Therapeutics
CDTX
$1.65B
$8.17M 0.57%
39,643
+2,500
+7% +$515K
PFNX
39
DELISTED
Pfenex Inc.
PFNX
$8.04M 0.56%
960,877
– –
CTMX icon
40
CytomX Therapeutics
CTMX
$346M
$7.58M 0.53%
742,021
– –
EYPT icon
41
EyePoint Pharmaceuticals
EYPT
$819M
$7.54M 0.52%
266,500
– –
FPRX
42
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$7.01M 0.49%
169,439
-284,690
-63% -$11.8M
NEPT
43
DELISTED
Neptune Wellness Solutions Inc. Ordinary Shares
NEPT
$6.89M 0.48%
4,822
– –
AKBA icon
44
Akebia Therapeutics
AKBA
$801M
$6.68M 0.46%
893,600
+28,600
+3% +$214K
RNAC icon
45
Cartesian Therapeutics
RNAC
$260M
$6.3M 0.44%
+15,000
New +$6.3M
MYOK
46
DELISTED
MyoKardia, Inc. Common Stock
MYOK
$6.24M 0.43%
502,894
– –
SIOX
47
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$6.23M 0.43%
60,625
– –
ZYNE
48
DELISTED
Zynerba Pharmaceuticals, Inc
ZYNE
$5.82M 0.4%
849,350
– –
FWP
49
DELISTED
Forward Pharma A/S American Depositary Shares
FWP
$5.66M 0.39%
44,486
+17,872
+67% +$2.27M
ACAD icon
50
Acadia Pharmaceuticals
ACAD
$4.3B
$5.36M 0.37%
165,240
-90,000
-35% -$2.92M
1
2
3 4 5